Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,818 | -5,885 | -4,315 | -21,312 | -10,421 |
| Depreciation Amortization | 1,026 | 512 | 2,137 | 1,613 | 1,119 |
| Income taxes - deferred | 6,562 | 4,885 | 3,795 | 1,472 | 1,317 |
| Accounts receivable | -12,415 | -7,223 | -9,905 | 1,015 | -2,015 |
| Other Working Capital | -10,968 | -7,109 | -15,166 | -5,782 | -3,203 |
| Other Operating Activity | 27,857 | 29,596 | 30,910 | 26,533 | 17,803 |
| Operating Cash Flow | $19,880 | $14,776 | $7,456 | $3,538 | $4,601 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -322 | -218 | -1,500 | -746 | -746 |
| Purchase Sale Intangibles | N/A | N/A | -900 | -900 | -900 |
| Other Investing Activity | 0 | 0 | -900 | -900 | -900 |
| Investing Cash Flow | $-322 | $-218 | $-2,400 | $-1,646 | $-1,646 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,257 | -4,092 | -336 | -246 | -366 |
| Common Stock Issued | 150 | N/A | 19 | N/A | N/A |
| Other Financing Activity | -140 | -39 | -509 | -443 | -130 |
| Financing Cash Flow | $-4,247 | $-4,131 | $-826 | $-689 | $-496 |
| Beginning Cash Position | 11,769 | 11,769 | 7,539 | 7,539 | 7,539 |
| End Cash Position | 27,081 | 22,196 | 11,769 | 8,742 | 9,999 |
| Net Cash Flow | $15,311 | $10,427 | $4,230 | $1,203 | $2,460 |
| Free Cash Flow | |||||
| Operating Cash Flow | 19,880 | 14,776 | 7,456 | 3,538 | 4,601 |
| Capital Expenditure | -322 | -218 | -1,625 | -871 | -871 |
| Free Cash Flow | 19,559 | 14,558 | 5,831 | 2,667 | 3,730 |